Drug manufacturer Johnson & Johnson recently touted a study that found bleeding side effects from Xarelto are relatively uncommon, only occurring in about 7% of patients. However, a more recent study has found that the methods used to determine the risks of internal bleeding may be unreliable and doctors should monitor their patients closely for increased risks.
Xarelto is an anticoagulant used to reduce the risk of blood clots in certain patients, including those who are recovering from surgeries or have a history of clots. The drug, which thins the blood, has also been associated with an increased risk of severe complications. Nearly 2,000 adverse events related to Xarelto have been reported to the U.S. Food and Drug Administration.
Xarelto side effects include blood clots, deep vein thrombosis and internal hemorrhaging. Because the drug does not contain a natural antidote like similar anticoagulants, internal bleeds while on Xarelto can be life-threatening. Almost 200 deaths have been linked to Xarelto.